The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001117303p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
5/08/2026
Date registered
Help: Date registered
9/09/2026
Date last updated
Help: Date last updated
9/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
9/09/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
The impact of short-term dairy intake on the pathophysiological pathway
of heatstroke in endurance trained individuals.
Scientific title
The impact of short-term dairy intake on the pathophysiological pathway
of heatstroke in endurance trained individuals aged 18 to 49 years.
Additional trial identifiers [1] 318096 0
Dairy Study
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Heat stroke 343143 0
Exercise-associated bacteraemia 343144 0
Condition category
Condition code
Diet and Nutrition 339227 339227 0 0
Other diet and nutrition disorders
Injuries and Accidents 339607 339607 0 0
Other injuries and accidents

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Arm 1 (treatment trial): twice daily (once in the AM, once in the PM) oral consumption for 7 days (in the participants location of choice) of 400 mL skim milk (cows milk) with beta-galactooligosaccharides and natural flavouring added. Adherence of consumption will be monitored via a consumption compliance data sheet. Participants will then complete 2 hours of running exercise at 60% of their pre-determined VO2max in 35 degrees celsius after completing the 7-day consumption of the skim milk beverage. There will be a minimum of 7 days of wash out between treatments.
Intervention code [1] 334980 0
Treatment: Other
Description of the comparator or control
Arm 2 (placebo trial): twice daily (once in the AM, once in the PM) oral consumption for 7 days (in the participants location of choice) of 400 mL almond milk with natural flavouring added. Adherence of consumption will be monitored via a consumption compliance data sheet. Participants will then complete 2 hours of running exercise at 60% of their pre-determined VO2max in 35 degrees celsius after completing the 7-day consumption of the almond milk beverage. There will be a minimum of 7 days of wash out between treatments.
Control group
Placebo

Outcomes
Primary outcome [1] 346461 0
Exercise-associated bacteraemia
Timepoint [1] 346461 0
Immediately pre- and post-exercise (2 hours of running in 35 degrees Celsius) after 7 days of treatment beverage provision.
Primary outcome [2] 346702 0
Bacterial profile
Timepoint [2] 346702 0
Immediately pre- and post-exercise (2 hours of running in 35 degrees Celsius) after 7 days of placebo beverage provision.
Secondary outcome [1] 465900 0
Gastrointestinal symptoms
Timepoint [1] 465900 0
Immediately pre- exercise trial, every 20 minutes during exercise trial, and every 15 minutes post exercise trial for a total of 2 hours post 7-days of treatment and/or placebo beverage consumption.

Eligibility
Key inclusion criteria
• 18 years or more, but no more than 49 years of age.
• Endurance trained individual.
• Minimum capacity of 45 mL/kg/min VO2max.
Minimum age
18 Years
Maximum age
49 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
• No health conditions that may affect participation (e.g., diabetes, cardiovascular disease, hypertension, liver or thyroid dysfunction, and/or a recent major surgery and/or implanted cardiac defibrillator).
• Not a smoker or vaper.
• Able to adhere to the study protocol and consume every study food.
• Available to attend three testing sessions at the BASE Facility, 264 Ferntree Gully Road, Notting Hill.
• Not pregnant, planning on becoming pregnant, and/or breastfeeding.
• Not an individual presenting a clinical diagnosis of gastrointestinal disease or disorders, or an individual presenting any other forms of illness or infection due to confounding effects on gastrointestinal markers/outcomes.
• No history of gastrointestinal surgery, and/or other self-reported gastrointestinal issues, consume potential modifiers of gastrointestinal integrity (such as prebiotics, probiotics, and/or antibiotics), adhering to gastrointestinal-focused dietary regimes (such as low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) or fibre-modified diets) within 3 months prior to study.
• No consumption of non-steroidal anti-inflammatory medications and/or stool-altering medications (e.g., laxatives and anti-diarrhoea) within 1 month prior to the experimental protocol.
• Not an individual presenting soft tissue injury 1 month prior to participation due to risk of recurrence of injury.
• Not an individual with lactose intolerance.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random sequence
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 322655 0
Commercial sector/Industry
Name [1] 322655 0
Dairy Council of the United States of America
Country [1] 322655 0
United States of America
Primary sponsor type
Individual
Name
Ricardo Costa - Monash University
Address
Country
Australia
Secondary sponsor category [1] 325580 0
University
Name [1] 325580 0
Monash University
Address [1] 325580 0
Country [1] 325580 0
Australia

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 321113 0
Monash University Human Research Ethics Committee
Ethics committee address [1] 321113 0
Ethics committee country [1] 321113 0
Australia
Date submitted for ethics approval [1] 321113 0
09/07/2026
Approval date [1] 321113 0
Ethics approval number [1] 321113 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 152710 0
Prof Ricardo Costa
Address 152710 0
Monash University, BASE Facility, 264 Ferntree Gully Road, Notting Hill, VIC,3205.
Country 152710 0
Australia
Phone 152710 0
+61 3 9905 6861
Fax 152710 0
Email 152710 0
Contact person for public queries
Name 152711 0
Ricardo Costa
Address 152711 0
Monash University, BASE Facility, 264 Ferntree Gully Road, Notting Hill, VIC,3205.
Country 152711 0
Australia
Phone 152711 0
+61 3 9905 6861
Fax 152711 0
Email 152711 0
Contact person for scientific queries
Name 152712 0
Ricardo Costa
Address 152712 0
Monash University, BASE Facility, 264 Ferntree Gully Road, Notting Hill, VIC,3205.
Country 152712 0
Australia
Phone 152712 0
+61 3 9905 6861
Fax 152712 0
Email 152712 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: Participant data will not be shared individually, rather, it will be published as a cohort post study completion.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.